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WHAT IS ALREADY KNOWN ON THIS TOPIC
Psychodynamic therapy (PDT) is widely practiced, but the empirical evidence for it is 
unclear.1 As relatively few well-controlled studies exist, some authors resort to meta-
analyses that include numerous poorly controlled and underpowered clinical trials in order to 
support their claim that PDT is efficacious.2
METHODS OF THE STUDY
After reviewing the distinction between superiority, non-inferiority and equivalency trials, 
Leichsenring and colleagues conducted a traditional literature search, which identified 64 
randomised controlled trials (RCTs) examining the efficacy of PDT in common mental 
health disorders. The authors then proceeded to provide their own interpretation of the 
literature by concluding that PDT is as effective as cognitive–behavioural therapy (CBT). 
However, this conclusion is unjustified given the poor or unknown quality of the studies 
included in this review.
WHAT DOES THIS PAPER ADD
▶ The general discussion about superiority, non-inferiority and equivalency trials 
was clear and accurate.
▶ This paper highlights problems in psychotherapy research. The authors provide a 
biased review of the literature, ignoring the quality of the data, and overstating 
the results. This article also reveals issues in the peer-review process of a high-
level psychiatry journal.
LIMITATIONS
▶ The term PDT is poorly defined and appears to identify a variety of different 
interventions. The authors defined this intervention as an ‘umbrella concept for 
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treatments that operate on an interpretive-supportive continuum’. It is difficult to 
imagine which forms of treatments do not meet this definition. CBT, for 
example, certainly does.
▶ The mechanism through which PDT is supposed to work remains unclear. The 
authors cited one study published in a book chapter, but none of the RCTs 
adequately examined treatment mediation.
▶ Treatments that ranged in length from 8 to 40 sessions were combined in the 
meta-analysis. This heterogeneity makes the results impossible to interpret.
▶ Attrition and dropout rates were not considered. Patients who benefit from 
treatment are more likely to stay in treatment, which may have biased the 
results.
▶ Therapy allegiance was not considered. This is particularly an issue for trials 
that compare PDT with CBT, because the trials comparing CBT with PDT are 
likely to have been conducted by PDT-oriented investigators.
▶ The placebo effect and common factors were not considered. No quality 
assessment of the individual trials was performed. Treatment integrity and 
adherence to the treatment protocol was not considered. The assessment 
methods of patients’ symptomatology appear to have been inadequate.
▶ The 64 RCTs that were identified were generally of poor quality and 
underpowered. The CBT literature shows a very large number of high-quality 
RCTs. A review of meta-analyses examining the efficacy of CBT yielded 269 
quantitative reviews.3 The vast majority of these studies showed clear superiority 
of CBT over other treatments and control conditions.
WHAT NEXT IN RESEARCH
Rather than conducting yet another review of essentially the same poorly controlled studies 
from a different perspective, this field needs high-quality RCTs that clearly demonstrate the 
efficacy of PDT. For example, the Cochrane Collaboration’s Tool is an instrument to 
quantify the risk of bias based on a number of criteria (eg, allocation concealment, blinding 
of participants and personnel, selective outcome reporting, etc).3 These trials will also need 
to test the hypothesised treatment mediation model. Without a clear understanding of the 
therapeutic process, it is difficult to distinguish them from other treatment modalities and to 
further improve the therapeutic strategies. In addition, therapy research has to identify 
patient characteristics that predict outcome.
DO THESE RESULTS CHANGE YOUR PRACTICES AND WHY?
No, this article does not provide any information that would change practice. Clinical 
practice should be based on empirical evidence. The empirical evidence for PDT is 
insufficient. The best evidence so far comes from high-quality RCTs comparing CBT and 
other treatments to adequate control groups.4 Based on this evidence, some countries have 
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begun large-scale dissemination efforts, leading to substantial reductions in overall 
healthcare cost. These are the most promising strategies to change clinical practice.
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